The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of nivolumab/ipilimumab in patients with initial or late progression with nivolumab: Updated analysis of a tailored approach in advanced renal cell carcinoma (TITAN-RCC).
 
Marc-Oliver Grimm
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Medac; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck Serono; MSD; Ono Pharmaceutical; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Emilio Esteban
No Relationships to Disclose
 
Philippe Barthélémy
Honoraria - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; ipsen; Janssen-Cilag; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; MSD; Pfizer
 
Manuela Schmidinger
Honoraria - ALKERMES; BMS; Eisai; EUSA Pharma; Ipsen; Merck Sharp & Dohme; MSD Oncology; Pfizer; Roche/Genentech
Consulting or Advisory Role - BMS; Eisai; EUSA Pharma; Ipsen; MSD Oncology; Pfizer; Roche
Travel, Accommodations, Expenses - BMS; Ipsen; Roche
 
Jonas Busch
Honoraria - Astellas Pharma; Bard Medical; Bristol-Myers Squibb; Ipsen; Merck; MSD; Pfizer; Roche
Consulting or Advisory Role - Bard Medical; Bristol-Myers Squibb; Ipsen; Merck; MSD; Pfizer; Roche
Expert Testimony - Bard Medical; Bayer; Bristol-Myers Squibb; Ipsen; Merck; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; Bard Medical; Bayer; Bristol-Myers Squibb; Ipsen; Merck; MSD; Pfizer; Roche
 
Begoña P. Valderrama
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pierre Fabre; Roche
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer; Roche
 
Marc Schmitz
No Relationships to Disclose
 
Ulrike Schumacher
No Relationships to Disclose
 
Gustavo Bruno Baretton
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche
Research Funding - MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Ignacio Duran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Immunomedics; Janssen Oncology; MSD Oncology; Novartis; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Ipsen; Roche/Genentech
 
Guillermo de Velasco
Honoraria - Ipsen; Pfizer
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; MSD; Novartis; Pfizer
Research Funding - Ipsen
Other Relationship - Janssen
 
Frank Priou
No Relationships to Disclose
 
Pablo Maroto-Rey
Research Funding - Roche (Inst)
 
Giovanni Schinzari
No Relationships to Disclose
 
Laurence Albiges
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Peloton therapeutics (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD